| Business Summary | | Harvard
Bioscience,
Inc.
is
a
provider
of
research
enabling
tools
for
drug
discovery.
The
Company
provides
an
array
of
tools
designed
to
accelerate
the
speed
and
to
reduce
the
cost
at
which
its
customers
can
introduce
new
drugs.
Since
its
1996
reorganization,
the
Company
has
focused
on
alleviating
the
protein
purification
and
absorption,
distribution,
metabolism,
elimination
and
toxicology
(ADMET)
screening
bottlenecks
in
drug
discovery.
The
Company's
products
consist
of
both
proprietary
and
non-proprietary
products.
The
Company's
Proteomics
Products
for
Protein
Purification
include
protein
purification
pipette
tips,
spin
columns,
protein
purification
dialyzers
and
disposable
equilibrium
dialyzers.
Proteomics
Products
for
protein
analysis
include
molecular
biology
spectrophotometers,
DNA/RNA/protein
calculators,
multi-well
plate
readers
and
amino
acid
analysis
systems. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Harvard
Bioscience,
Inc.
provides
research-ennabling
tools
for
drug
discovery
research
at
pharmaceutical
and
biotechnology
companies,
universities
and
government
research
laboratories.
For
the
six
months
ended
6/30/01,
revenues
rose
27%
to
$18.3
million.
Net
loss
applicable
to
Common
fell
92%
to
$5.1
million.
Revenues
reflect
organic
growth
from
acquired
product
lines.
Lower
loss
reflects
the
absence
of
a
$67.5
million
warrant
interest
expense. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Chane Graziano, 62 CEO,
Director | $508K | $15M | David Green, 36 Pres,
Director | 455K | 15M | Susan Luscinski, 44 CFO | 163K | 411K | Mark Norige, 46 COO | 155K | 307K | John House, 56 Managing
Director, Biochrom Ltd | -- | -- | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|